TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells. (14th May 2019)
- Record Type:
- Journal Article
- Title:
- TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells. (14th May 2019)
- Main Title:
- TNF-Stimulated Gene-6 Is a Key Regulator in Switching Stemness and Biological Properties of Mesenchymal Stem Cells
- Authors:
- Romano, Barbara
Elangovan, Sudharshan
Erreni, Marco
Sala, Emanuela
Petti, Luciana
Kunderfranco, Paolo
Massimino, Luca
Restelli, Silvia
Sinha, Shruti
Lucchetti, Donatella
Anselmo, Achille
Colombo, Federico Simone
Stravalaci, Matteo
Arena, Vincenzo
D'Alessio, Silvia
Ungaro, Federica
Inforzato, Antonio
Izzo, Angelo A.
Sgambato, Alessandro
Day, Anthony J.
Vetrano, Stefania - Abstract:
- Abstract: Mesenchymal stem cells (MSCs) are well established to have promising therapeutic properties. TNF-stimulated gene-6 (TSG-6), a potent tissue-protective and anti-inflammatory factor, has been demonstrated to be responsible for a significant part of the tissue-protecting properties mediated by MSCs. Nevertheless, current knowledge about the biological function of TSG-6 in MSCs is limited. Here, we demonstrated that TSG-6 is a crucial factor that influences many functional properties of MSCs. The transcriptomic sequencing analysis of wild-type (WT) and TSG-6 −/− -MSCs shows that the loss of TSG-6 expression leads to the perturbation of several transcription factors, cytokines, and other key biological pathways. TSG-6 −/− -MSCs appeared morphologically different with dissimilar cytoskeleton organization, significantly reduced size of extracellular vesicles, decreased cell proliferative rate, and loss of differentiation abilities compared with the WT cells. These cellular effects may be due to TSG-6-mediated changes in the extracellular matrix (ECM) environment. The supplementation of ECM with exogenous TSG-6, in fact, rescued cell proliferation and changes in morphology. Importantly, TSG-6-deficient MSCs displayed an increased capacity to release interleukin-6 conferring pro-inflammatory and pro-tumorigenic properties to the MSCs. Overall, our data provide strong evidence that TSG-6 is crucial for the maintenance of stemness and other biological properties of murineAbstract: Mesenchymal stem cells (MSCs) are well established to have promising therapeutic properties. TNF-stimulated gene-6 (TSG-6), a potent tissue-protective and anti-inflammatory factor, has been demonstrated to be responsible for a significant part of the tissue-protecting properties mediated by MSCs. Nevertheless, current knowledge about the biological function of TSG-6 in MSCs is limited. Here, we demonstrated that TSG-6 is a crucial factor that influences many functional properties of MSCs. The transcriptomic sequencing analysis of wild-type (WT) and TSG-6 −/− -MSCs shows that the loss of TSG-6 expression leads to the perturbation of several transcription factors, cytokines, and other key biological pathways. TSG-6 −/− -MSCs appeared morphologically different with dissimilar cytoskeleton organization, significantly reduced size of extracellular vesicles, decreased cell proliferative rate, and loss of differentiation abilities compared with the WT cells. These cellular effects may be due to TSG-6-mediated changes in the extracellular matrix (ECM) environment. The supplementation of ECM with exogenous TSG-6, in fact, rescued cell proliferation and changes in morphology. Importantly, TSG-6-deficient MSCs displayed an increased capacity to release interleukin-6 conferring pro-inflammatory and pro-tumorigenic properties to the MSCs. Overall, our data provide strong evidence that TSG-6 is crucial for the maintenance of stemness and other biological properties of murine MSCs. : Abstract : Loss of TNF-stimulated gene-6 (TSG-6) in murine mesenchymal stem cells drives changes in cell morphology and actin-cytoskeleton organization that ultimately impact cell proliferation and differentiation capacities of mesenchymal stem cells. TSG-6 regulates the expression of transcription factors involved in several mesenchymal stem cell cellular processes, crucial for the maintenance of stemness and key biological properties. Its loss led to the abrogation of immunomodulatory properties conferring to mesenchymal stem cells, a pro-tumorigenic phenotype by an increased capacity to release interleukin-6. … (more)
- Is Part Of:
- Stem cells. Volume 37:Number 7(2019)
- Journal:
- Stem cells
- Issue:
- Volume 37:Number 7(2019)
- Issue Display:
- Volume 37, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 37
- Issue:
- 7
- Issue Sort Value:
- 2019-0037-0007-0000
- Page Start:
- 973
- Page End:
- 987
- Publication Date:
- 2019-05-14
- Subjects:
- Cloning -- Periodicals
Clone cells -- Periodicals
Stem cells -- Periodicals
Cell Differentiation -- Periodicals
Cell Division -- Periodicals
Clone Cells -- Periodicals
Hematopoietic Stem Cells -- Periodicals
Stem Cells -- Periodicals
571.84 - Journal URLs:
- https://academic.oup.com/stmcls ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/stem.3010 ↗
- Languages:
- English
- ISSNs:
- 1066-5099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8464.133510
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20737.xml